Ichtiolowa Hasco (Ichthammol)

Ichthammol releases sulfur‑based compounds that provide antibacterial, anti‑inflammatory and keratolytic actions. These compounds inhibit neutrophil migration, break down excess keratin, and suppress bacterial growth, which together reduce local inflammation and promote drainage of suppurative lesions.

The exact dosing regimen is determined by the prescribing clinician. Typically, a thin layer is applied to the affected area once or twice daily, after cleaning the skin. The prescriber will adjust frequency and duration based on the severity of the condition.

Safety data for ichthammol in pregnancy and lactation are limited. It should be used only if the potential benefit justifies any possible risk to the fetus or infant, and only under medical supervision.

To order, submit an enquiry on the product page at gnhindia.com, specifying the required quantity. GNH India works with hospitals, pharmacies and procurement teams worldwide, verifies trade or institutional credentials, and then provides pricing, availability, shipping details and any necessary import documentation.

Compared with topical antibiotics such as mupirocin, ichthammol offers both anti‑inflammatory and antiseptic benefits without the risk of antibiotic resistance. It is less potent as an antimicrobial but provides keratolytic action, making it useful for lesions where debris removal is important.

Store the product at room temperature, below 25 °C, in its original container. Keep it away from moisture, direct sunlight and extreme heat. Ensure the lid is tightly closed after each use to maintain product stability.

Ichtiolowa Hasco is applied topically. Clean the affected skin area, then spread a thin layer of the preparation over the lesion using a sterile applicator or clean fingertip. Avoid contact with eyes, mucous membranes and broken skin not related to the target lesion.

Serious risks include severe allergic reactions such as anaphylaxis, bullous dermatitis, ulceration of the skin and, very rarely, systemic toxicity from excessive absorption. Patients should discontinue use and seek medical attention if they experience swelling, difficulty breathing, large blisters or deep skin breakdown.

Individuals with a known hypersensitivity to ichthammol or any component of the formulation should avoid use. It is also contraindicated in infants under two years of age unless directed by a physician, and should be used with caution during pregnancy or lactation.